Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications for the page Advisory, Warning & Recall Notices

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 1 of 10
Date Title
14/06/2013 Questran- Important information from BMS on precautionary pharmacy level recall, as approved by the Irish Medicines Board
06/06/2013 Field Safety Notice Monthly Summary Sheet May 2013
17/05/2013 Avastin (bevacizumab) Important Safety Information from Roche as approved by the Irish Medicines Board
17/05/2013 Synacthen (tetracosactide) Important Safety Information from SOBI AB as approved by the Irish Medicines Board
15/05/2013 Protelos (strontium ranelate) Important Safety Information from Servier as approved by the Irish Medicines Board
07/05/2013 Increlex (mecasermin) Important Safety Information from Ipsen as approved by the Irish Medicines Board
03/05/2013 Fastum Gel (ketoprofen) Important Safety Information from A. Menarini as approved by the Irish Medicines Board
02/05/2013 Field Safety Notice Monthly Summary Sheet - April 2013
24/04/2013 Display of chemical group symbols on product literature of sheep anthelmintics
19/04/2013 Thalidomide Celgene (thalidomide) Important Safety Information from Celgene as approved by the Irish Medicines Board
15/04/2013 MabThera (rituximab) Important Safety Information from Roche Products (Ireland) Limited as approved by the Irish Medicines Board
09/04/2013 Incivo (telaprevir) Important Safety Information from Janssen as approved by the Irish Medicines Board
27/03/2013 Mimpara (cinacalcet) Important Safety Information from Amgen Ireland Limited as approved by the Irish Medicines Board
20/03/2013 Nulojix (belatacept) Important Safety Information from Bristol-Myers Squibb Pharmaceuticals as approved by the Irish Medicines Board
05/03/2013 Vistide (Cidofovir) Important Safety Information from Gilead Sciences International Limited as approved by the Irish Medicines Board
04/03/2013 Field Safety Notice Monthly Summary Sheet - February 2013
26/02/2013 NeuroBloc (Botulinum Toxin Type B) Important Safety Information from Eisai Ltd as approved by the Irish Medicines Board
21/02/2013 Prolia (denosumab) Important Safety Information from Amgen Ireland Limited as approved by the Irish Medicines Board
04/02/2013 Xagrid (anagrelide hydrochloride) - Important Safety Information from Shire as approved by the Irish Medicines Board
01/02/2013 Field Safety Notice Monthly Summary Sheet - January 2013
Page 1 of 10



Date Printed: 18 June 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971